Cargando…
Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107069/ https://www.ncbi.nlm.nih.gov/pubmed/33826091 http://dx.doi.org/10.1007/s12325-021-01683-0 |
| _version_ | 1783689887774408704 |
|---|---|
| author | Mougalian, Sarah S. Kish, Jonathan K. Zhang, Jingchuan Liassou, Djibril Feinberg, Bruce A. |
| author_facet | Mougalian, Sarah S. Kish, Jonathan K. Zhang, Jingchuan Liassou, Djibril Feinberg, Bruce A. |
| author_sort | Mougalian, Sarah S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8107069 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81070692021-05-24 Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States Mougalian, Sarah S. Kish, Jonathan K. Zhang, Jingchuan Liassou, Djibril Feinberg, Bruce A. Adv Ther Correction Springer Healthcare 2021-04-07 2021 /pmc/articles/PMC8107069/ /pubmed/33826091 http://dx.doi.org/10.1007/s12325-021-01683-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Mougalian, Sarah S. Kish, Jonathan K. Zhang, Jingchuan Liassou, Djibril Feinberg, Bruce A. Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States |
| title | Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States |
| title_full | Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States |
| title_fullStr | Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States |
| title_full_unstemmed | Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States |
| title_short | Correction to: Effectiveness of Eribulin in Metastatic Breast Cancer: 10 Years of Real-World Clinical Experience in the United States |
| title_sort | correction to: effectiveness of eribulin in metastatic breast cancer: 10 years of real-world clinical experience in the united states |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107069/ https://www.ncbi.nlm.nih.gov/pubmed/33826091 http://dx.doi.org/10.1007/s12325-021-01683-0 |
| work_keys_str_mv | AT mougaliansarahs correctiontoeffectivenessoferibulininmetastaticbreastcancer10yearsofrealworldclinicalexperienceintheunitedstates AT kishjonathank correctiontoeffectivenessoferibulininmetastaticbreastcancer10yearsofrealworldclinicalexperienceintheunitedstates AT zhangjingchuan correctiontoeffectivenessoferibulininmetastaticbreastcancer10yearsofrealworldclinicalexperienceintheunitedstates AT liassoudjibril correctiontoeffectivenessoferibulininmetastaticbreastcancer10yearsofrealworldclinicalexperienceintheunitedstates AT feinbergbrucea correctiontoeffectivenessoferibulininmetastaticbreastcancer10yearsofrealworldclinicalexperienceintheunitedstates |